New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing
-
Timescale and Grafana Labs Integration Enhances Time-Series Data Exploration and Visualization for Organizations
-
SetPoint Medical Completes Enrollment in U.S. Pilot Study Evaluating Bioelectronic Device for Treatment of Rheumatoid Arthritis
-
Form SC 13D/A Nightstar Therapeutics Filed by: New Enterprise Associates 15, L.P.
-
Ledger Capital Partners with Opera Software to Grow its Blockchain Technology Initiative
-
NEA Promotes Paul Walker to General Partner
-
OmniSci (formerly MapD) Secures $55 Million in New Funding
-
MapD Rebrands to OmniSci
-
Stride Expands Leadership Team To Scale Its Benefits Platform for Gig and Independent Workers
-
NYC's Ascent Conference Announces Partner and Speaker Lineup
-
Topia's New Deferred Compensation Tool Delivers Fast, Accurate Cost Estimates for Global Moves
-
Silicon Valley Technology Executive Lily Shen Joins Transfix as Chief Operating Officer
-
Logix Federal Credit Union Selects Veriflow for Network Segmentation Verification
-
Robert Simonds' STX Adds Country Music Superstar Blake Shelton To UGLYDOLLS Cast
-
Galera Therapeutics Raises $150 Million for GC4419 Phase 3 Trial and Pre-Commercialization Activities in Lead Indication
-
Galera Therapeutics Raises $150 Million for GC4419 Phase 3 Trial and Pre-Commercialization Activities in Lead Indication
-
Form SC 13D Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
-
Roivant Launches Respivant Sciences to Develop Innovative Therapeutics for Respiratory Diseases
-
Industry Leader Jeffrey Wang Joins Veriflow as VP of Engineering
-
ViewLift Powers New Professional Fighters League Website
-
Robert Simonds' STX Adds Comedians Gabriel Iglesias & Wanda Sykes To All-Star UGLYDOLLS Cast
-
MapD Joins NVIDIA and Pure Storage to Unlock Analytics for a New Era of Intelligence
-
Timescale Announces TimescaleDB 1.0—Empowering Organizations to Leverage Time-Series Data to Analyze the Past, Understand the Present, and Predict the Future
-
StreamSets Brings DataOps to Hybrid Cloud Architectures
-
StreamSets Raises $35 Million in Series C Funding Round Led by Harmony Partners
-
New Study Reveals Talent-Mobility Disconnect That Fuels Employee Turnover
-
CIT GAP Funds Portfolio Company, TypeZero Technologies, Acquired by Dexcom
-
With Shipping to Customers Underway, Desktop Metal Introduces Studio System+ and Studio Fleet
-
PhaseBio Secures $34 Million in Series D Financing
-
PhaseBio Secures $34 Million in Series D Financing
-
Adaptimmune Therapeutics (ADAP) Announces $100M Registered Direct Offering of ADSs
-
Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares
-
Dermavant Announces Changes to Leadership and Board of Directors
-
Sonatype’s Latest Nexus Intelligence Shines a Light on Hidden JavaScript Vulnerabilities and Empowers Developers with Actionable Insights
-
Sonatype’s Latest Nexus Intelligence Shines a Light on Hidden JavaScript Vulnerabilities and Empowers Developers with Actionable Insights
-
Bob Simonds' STX Adds Nick Jonas to Star-Studded UGLYDOLLS Film
-
Tempus Announces $110 Million in Series E Financing
-
Tempus Announces $110 Million in Series E Financing
-
CIT GAP Funds Invests in Embody
-
Roivant Sciences Provides Corporate Update
-
Paladina Health Receives $165M Investment from NEA and New Investors
-
Sitetracker Raises $24 Million in Series B Funding to Fuel Continued Innovation and Global Expansion
-
VividCortex Ranks No. 244 on 2018 Inc. 500 List of Fastest-Growing Private Companies in America
-
Symphony Ventures Partners with a Global RPA Leader, Automation Anywhere
-
Sonatype Launches DepShield App to Democratize Open Source Governance
-
Sonatype Launches DepShield App to Democratize Open Source Governance
-
The Great Courses Plus Announces Voice-Activated Audio Streaming
-
Pandora Selects Veriflow CloudPredict for Multi-Cloud Intent-Based Verification
-
Ivantis Announces FDA Approval for Its Innovative Hydrus® Microstent Device for Minimally Invasive Glaucoma Surgery (MIGS)
-
SetPoint Medical Appoints Murthy Simhambhatla as President and Chief Executive Officer

